Coronavirus

Should I Get a COVID Booster Shot This Fall?

Yes, you should. Studies have shown that the initial vaccine doses lose efficacy over time, and a booster dose will bolster immune responses from the original series of vaccines.

Shandra Ahsan31 Oct 2022

COVID-19

What does "Fully Vaccinated" Mean in 2023

As of October 2022, the CDC still considers fully vaccinated to mean two weeks after their second dose of the Moderna or Pfizer series or two weeks after the single dose Johnson and Johnson vaccine.

Alexandra Thompson27 Dec 2022

COVID-19

What Vaccine will Work for Omicron BA.5?

In the U.S. there are currently four vaccines available to protect against severe COVID-19, including the Omicron BA.5 variant. Pfizer and Moderna are currently developing updated vaccines to specifically target new versions of Omicron that are predicted to be available in Fall 2022.

Erica Kahn30 Aug 2022

COVID-19

What is Paxlovid Rebound?

Paxlovid rebounding is defined as the return of covid-19 symptoms and/or new positive COVID-19 test after having tested negative and completing the paxlovid treatment. This phenomenon has been seen in both unvaccinated and vaccinated individuals.

Alexandra Thompson23 Aug 2022

Public Health

What to Know About Novavax and Covid-19

Novavax is a Maryland-based biotechnology company that investigates and counters serious infectious diseases through vaccine creation and development. Novavax developed one authorized COVID-19 vaccine with a 90% effectiveness for those who are 18 years and older.

Alexandra Thompson23 Aug 2022

COVID-19

How Contagious is Monkeypox Compared to COVID-19?

According to our research, Monkeypox has a reproduction rate R of 0.85, compared to 8.2 that of the Omicron variant of COVID-19, making Monkeypox less contagious than COVID-19. Research on Monkeypox has been around for over 20 years. Monkeypox isn’t a new virus or variation. However, the viral infection has seen a spike in interest as communities in the UK and Canada have increased outbreaks.

Khang T. Vuong, MHA25 Jul 2022

Insights

Companies Hiring for Remote Work

When looking for a remote job, read the job description carefully, and be sure to clarify during the interview if you are still unsure about the remote work policy. With an increased desire of employees to work remotely, some companies have switched to offering permanent remote options.

Alexandra Thompson23 Aug 2022

COVID-19

Does the COVID-19 Vaccine Protect Against the Omicron Variant?

The currently available COVID-19 vaccines protect against severe illness, hospitalizations, and deaths due to the Omicron variant. Breakthrough infections in people who are fully vaccinated may occur, but most vaccinated individuals have reported mild or no symptoms from the Omicron variant.

Alexis Bryan23 Aug 2022

COVID-19

Should I Go To Urgent Care for a COVID-19 Test?

Urgent care centers are a convenient way to get a COVID-19 test, but may charge a fee or require you to pay out-of-pocket if they are not “in-network”. COVID-19 tests are available in a variety of settings, including at state or locally administered testing sites, drive-thru sites, walk-up sites, and urgent care centers.

Alexis Bryan12 Dec 2022

COVID-19

Is the COVID-19 Vaccine Effective Against the Delta Variant?

More infectious strains, like the Delta variant, pose a threat to protection from the currently approved COVID-19 vaccines. At this time, vaccines are working. COVID-19 vaccination prevents severe illness, hospitalization, and death from the SARS-CoV-2 virus, but breakthrough cases are expected.

Alexis Bryan23 Aug 2022

COVID-19

Everything You Need to Know About the Sinovac Vaccine

The Sinovac vaccine, CoronaVac, is an inactivated vaccine developed by a private Chinese company. It requires two doses given 2-4 weeks apart, similar to mRNA vaccines and most adenovector vaccines. Currently, the Sinovac vaccine is approved in China and for emergency use in other countries.

Alexis Bryan23 Aug 2022

Insights

New York City COVID-19 Vaccine Eligibility

Pfizer-BioNTech, Moderna, and Johnson & Johnson have all received emergency use authorization from the FDA for the use of their Covid-19 vaccines. New York is following a phased distribution of the Covid-19 vaccine. This means that only people identified as eligible in the current phases will be able to receive the vaccine. Currently, only those in Phase 1A and Phase 1B are eligible to receive the vaccine.

Spencer Lee25 Mar 2021